Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice


Creative Commons License

Spelman T., Meyniel C., Ignacio Rojas J., Lugaresi A., Izquierdo G., Grand'Maison F., ...Daha Fazla

MULTIPLE SCLEROSIS JOURNAL, cilt.23, ss.1346-1357, 2017 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 23 Konu: 10
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1177/1352458516679893
  • Dergi Adı: MULTIPLE SCLEROSIS JOURNAL
  • Sayfa Sayıları: ss.1346-1357

Özet

Background: Characteristics at clinically isolated syndrome (CIS) examination assist in identification of patient at highest risk of early second attack and could benefit the most from early disease-modifying drugs (DMDs).